Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice

The association between chronic hepatitis C infection and cardiovascular risk

(2016) P. Pateria et al.   INTERNAL MEDICINE JOURNAL

The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand

(2016) Jessica Howell et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Arrested Hematopoiesis and Vascular Relaxation Defects in Mice with a Mutation inDhfr

(2016) Julie A. I. Thoms et al.   MOLECULAR AND CELLULAR BIOLOGY

Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease

(2016) Vera H. I. Fengler et al.   PLoS One

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess

(2015) Leila Idrissova et al.   JOURNAL OF HEPATOLOGY

Lipid-Overloaded Enlarged Adipocytes Provoke Insulin Resistance Independent of Inflammation

(2015) Jong In Kim et al.   MOLECULAR AND CELLULAR BIOLOGY

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms

(2015) B. A. Di Bartolo et al.   Journal of the American Heart Association

TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE-/- Mice

(2014) Siân P. Cartland et al.   PLoS One

Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand

(2013) Nor Saadah M. Azahri et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Fas andFasLExpression in Human Adipose Tissue Is Related to Obesity, Insulin Resistance, and Type 2 Diabetes

(2013) Matthias Blüher et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association

(2013) Harold E. Bays et al.   Journal of Clinical Lipidology

High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation

(2013) Kristine C. McGrath et al.   JOURNAL OF LIPID RESEARCH

TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL

(2013) Belinda A. Di Bartolo et al.   PLoS One

On the TRAIL of obesity and diabetes

(2013) Hanis H. Harith et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation

(2012) Stella Bernardi et al.   CLINICAL SCIENCE

PAQR3 Modulates Insulin Signaling by Shunting Phosphoinositide 3-Kinase p110  to the Golgi Apparatus

(2012) X. Wang et al.   DIABETES

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients

(2012) A. Bisgin et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis

(2012) Christopher Savard et al.   HEPATOLOGY

Non-alcoholic fatty liver disease

(2011) Briohny W. Smith et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice

(2011) B. A. Di Bartolo et al.   DIABETOLOGIA

Death Receptor 5 Signaling Promotes Hepatocyte Lipoapoptosis

(2011) Sophie C. Cazanave et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt

(2010) Stephan Wueest et al.   FEBS LETTERS

The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38MAPKPathways

(2010) Dan Gao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients

(2010) S. Liabeuf et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Vascular insulin resistance: A potential link between cardiovascular and metabolic diseases

(2009) Ivonne Hernandez Schulman et al.   CURRENT HYPERTENSION REPORTS

Mechanisms of TNF-α-induced insulin resistance

(2009) G. Hotamisligil   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the united states population

(2009) George N. Ioannou et al.   HEPATOLOGY

sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease

(2009) Xiaohua Yan et al.   IMMUNOGENETICS

Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression

(2009) Geoffrey C Farrell et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Death Receptors and Their Ligands in Atherosclerosis

(2008) Mary M. Kavurma et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice

(2008) Shuqin Zheng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cellular and Molecular Mechanisms of Liver Injury

(2008) Harmeet Malhi et al.   GASTROENTEROLOGY

The Death Ligand TRAIL in Diabetic Nephropathy

(2008) C. Lorz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Expression, regulation and function of trail in atherosclerosis

(2007) Mary M. Kavurma et al.   BIOCHEMICAL PHARMACOLOGY